[Update on Recommendations for SARS-CoV-2/COVID-19 During Pregnancy, Birth and Childbed]

Janine Zöllkau1, Carsten Hagenbeck2, Kurt Hecher3

  • 1Klinik für Geburtsmedizin, Universitätsklinikum Jena.

Insights

Updated recommendations for pregnant and newborn care during the SARS-CoV-2 pandemic are provided, addressing critical questions for obstetric, neonatal, and pediatric professionals. These expert consensus statements guide management based on the latest evidence.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Pediatrics
  • Infectious Diseases

Background:

  • The SARS-CoV-2 pandemic necessitated initial care recommendations for pregnant individuals and newborns in March 2020.
  • Rapidly evolving knowledge requires continuous updates to clinical guidelines.
  • Existing recommendations serve as a foundation for this updated guidance.

Purpose of the Study:

  • To provide an updated expert consensus on key questions regarding prenatal, perinatal, and postnatal care for COVID-19.
  • To supplement and prosecute previous recommendations issued by German professional societies.
  • To offer evidence-based guidance for healthcare professionals managing pregnant individuals and newborns during the pandemic.

Main Methods:

  • A review and commentary on key questions related to SARS-CoV-2 and COVID-19 in obstetric and neonatal care.
  • Based on publications available up to May 30, 2020.
  • Methodologically dependent on a consensual review of worldwide national recommendations.

Main Results:

  • The update addresses critical aspects of maternal and neonatal care in the context of SARS-CoV-2 infection.
  • Statements reflect a consensus among experts, acknowledging the dynamic nature of scientific understanding.
  • Guidance is provided for pre-, peri-, and postnatal management strategies.

Conclusions:

  • These updated recommendations offer a framework for managing pregnant individuals and newborns during the COVID-19 pandemic.
  • Local medical teams retain responsibility for patient management, utilizing these recommendations for support.
  • The statements are subject to change as new scientific evidence emerges.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.3K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
749
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.6K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K